Metasight Demonstration Catalog
Explore our solution
  • Home
  • Catalog
  • Guide
  • About
  • Login
    Login
    Home / Central Data Catalog / PROJECT.REBECCA2
central

REBECCA-2
REBECCA-2

Reference ID
Project.REBECCA2
Collections
Clinical Trial
Metadata
DDI/XML JSON
Created on
Jul 07, 2026
Last modified
Jul 07, 2026
Page views
6804
  • Study Description
  • Data Dictionary
  • Data files
  • REBECCA2_2025-10-22_1440.REDCap.xml
Variable Groups
  • Background
  • Randomization
  • Event General Info Form
  • End of Study
  • Biological Samples And Measurements
  • Clinical Exams
  • Medication Information
  • Currentassessment
  • Ueq
  • PROMs
  • Qol Cervantes
  • FSS
  • Vasquestionnaire
  • Hads
  • Phq2
  • Gad7
  • Dietquestionnaire
  • Eortcqlqc30
  • Mui
  • Bergen Insomnia Scale
  • Sfnsiq
  • Chalder Fatigue Scale
  • History
  • Demographics
  • TumorInformation
  • Treatment
  • Compliance
  • Eortcqlqbr23
  • Factb
  • K10
  • Sf36
  • Fact Gog Ntx
  • Utah Early Neuropathy Scale
  • Rebecca Intervention Form
  • Early Warning System
  • Wp6p Evaluation

Variable Groups

Variable group: Treatment
Variables 65
antibody
Antibody treatment
antibodystartdate
Start date of antibody treatment
antibodytreattype
Treatment
axillaryengagement
Axillary engagement (SN and / or evacuation)
axillaryinterventionresult
End result axillary intervention
axillarysurgsecondsessiom
Complementary axillary procedure performed in a second session
bisph
Bisphosphonates
boost
Total excl. Boost
boostdoses
Boost doses
breastconcervation
Breast_concervation_1
breastconcervation2
Breast_concervation_2
breastsurgeryresult
End result of breast surgery.
changedtreatmentperiod
Specify the period the treament was received (in months).
changedtreatmenttype
What type of hormonal treatment did the patient receive after change?
changereason
Reason for interruption / change
clinicalstudiespart
Participation in clinical studies
clinicalstudydetails
Details about clinical study
comalignancy
What co malignancy does the patient have
completedtreatment
Treatment completed according to plan
complsurgery
Number of complementary breast surgery and / or axill which are made due to tumor data.
curedate
Start date first cure
curestart
Start date first cure
deathdate
Date_death_or_last_FU
dissection1
Axille_Dissection_1
dissection2
Axille_Dissection_2
dosetarget
Target
ec
EC
ecthreatmenttype
Treatment
endocrine
Endocrine treatment
endocrinetreatmenttype
Treatment
fec
FEC
fececend
When did the FEC or EC treatment End?
fececstart
When did the FEC or EC treatment Start?
firstdosedate
Start date, first dose
firsttreatmentdate
Date of first treatment
herceptin
Did the patient receive Herceptin treatment?
herceptinend
When did the Herceptin treatment End?
herceptinstart
When did the Herceptin treatment Start?
inpatientcare
Inpatient care due to treatment complications
lastmodified_treat
masectomy2
Mastectomy_2
mastectomy1
Mastectomy_1
nofollowup
No further follow-up
nopostonco
No postoperative oncological treatment.
nosurgicaltreatment
No investigation of surgical treatment
oncologydate
Date of oncology therapeutic recommendation.
oncoplasticsurgery
Oncoplastic surgery
oncotreatment
Investigation of oncological treatment
oncotreatmenttype
Specify oncological treatment
operatedate
Operating date 1st: the procedure
operationtype
Type of operation (if any).
othermeds
What other medicine does the patient take?
paddate
Date of 1st postoperative PAD information to patient.
plannedaction
Planned action.
postoncoplanned
Planned postoperative oncological treatment.
radiation
Radiation therapy
relapsestatus
Relapse status.
reresection1
Reresection_1
reresection2
Reresection_2
surgerysecondsession
Complementary breast surgery performed in a second session
taxotere
Did the patient receive Taxotere treatment?
treatment_complete
Complete?
whynofollowup
Reasons for no further follow-up
whynooncotreatment
Reason for no oncological treatment
zometa
Did the patient receive bisphosphate/zoledronic acid?
Back to Catalog

© Metasight, All Rights Reserved.